Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
European Medicines Agency
Pharma
EU regulators offer post-mortem of Tavneos withdrawal decision
EU regulators have outlined concerns that led to last week's formal revocation of the marketing authorization for the rare-disease med Tavneos.
Fraiser Kansteiner
Aug 14, 2026 11:04am
Regulatory tracker: Akeso's ivonescimab wins key nod in China
Aug 12, 2026 9:13am
Regulatory tracker: FDA starts review of Sandoz's generic tirzepatide
Jun 29, 2026 10:38am
Europe's CHMP reverses endorsement of Amgen's Tavneos
Jun 26, 2026 11:07am
Zevra CEO drafts big ambitions for Miplyffa's US adoption curve
Jun 3, 2026 11:17am
EU regulator recommends AZ's Etcamah, Novo's Wegovy pill
May 22, 2026 11:58am
